Kavya Rakhra

Learn More
Doxorubicin (DOX) is a member of the anthracycline class of chemotherapeutic agents used for the treatment of many common human cancers including aggressive non-Hodgkin's lymphoma [1, 2]. However, DOX is highly toxic in humans resulting in severe suppression of hematopoiesis, gastrointestinal toxicity [3] , and cardiac toxicity [4]. To date, several(More)
  • 1